Oral Solid Dosage Forms (OSDF) and Pharma Excipients

Oral Solid Dosage Forms (OSDF) and Pharma Excipients

Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market to Reach $1.6 Billion by 2030
The global market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients estimated at US$1.1 Billion in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Polymers, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$846.6 Million by the end of the analysis period. Growth in the Alcohols segment is estimated at 4.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $341.3 Million, While China is Forecast to Grow at 4.7% CAGR
The Oral Solid Dosage Forms (OSDF) and Pharma Excipients market in the U.S. is estimated at US$341.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$280.7 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 4.1% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 46 Featured) -
  • Abitec Corporation
  • Akzo Nobel NV
  • Archer Daniels Midland Company
  • Associated British Foods PLC
  • Avantor Performance Materials LLC
  • BASF SE
  • Cabot Corporation
  • Cargill, Inc.
  • Celanese Corporation
  • Croda International PLC
  • Dow, Inc.
  • DuPont de Nemours, Inc.
  • Eastman Chemical Company
  • Ferro Corporation
  • FMC Corporation
  • FMC Corporation
  • Huntsman Corporation
  • Ingredion, Inc.
  • Innophos Holdings, Inc.
  • J.M. Huber Corporation
  • Kuraray Co., Ltd.
  • Medtronic PLC
  • Merck KGaA
  • Nitta Gelatin, Inc.
  • Procter & Gamble Company, The
  • Royal Dutch Shell PLC
  • The Lubrizol Corporation
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Oral Solid Dosage Forms (OSDF) and Pharma Excipients - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Polymers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Alcohols by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Alcohols by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Alcohols by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Minerals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Gelatin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Gelatin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Gelatin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 21: USA Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: USA 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030
CANADA
TABLE 23: Canada Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: Canada Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: Canada 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030
JAPAN
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 26: Japan Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: Japan Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: Japan 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030
CHINA
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 29: China Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: China Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: China 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030
EUROPE
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 32: Europe Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 33: Europe Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: Europe 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 35: Europe Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Europe Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Europe 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030
FRANCE
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 38: France Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: France Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: France 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030
GERMANY
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 41: Germany Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Germany Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Germany 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030
ITALY
TABLE 44: Italy Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Italy Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Italy 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030
UNITED KINGDOM
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 47: UK Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: UK Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: UK 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Rest of Europe Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Rest of Europe 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Asia-Pacific Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Asia-Pacific 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 56: Rest of World Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Rest of World Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Rest of World 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings